Restart Life Sciences Corp.
Restart Life Sciences Corp., through its subsidiaries, operates as a biotechnology company worldwide. It engages in developing diagnostics and psilocybin-based therapeutics for the treatment of neuroinflammatory disorders, including autism spectrum disorder and fragile X syndrome. The company was formerly known as Nova Mentis Life Science Corp. and changed its name to Restart Life Sciences Corp. … Read more
Market Cap & Net Worth: Restart Life Sciences Corp. (NMLSD)
Restart Life Sciences Corp. (PINK:NMLSD) has a market capitalization of $503.79 ($503.79) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #48805 globally and #14989 in its home market, demonstrating a 2.06% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Restart Life Sciences Corp.'s stock price $0.05 by its total outstanding shares 9227 (9.23K).
Restart Life Sciences Corp. Market Cap History: 2020 to 2025
Restart Life Sciences Corp.'s market capitalization history from 2020 to 2025. Data shows change from $7.76K to $503.79 (-46.24% CAGR).
Restart Life Sciences Corp. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Restart Life Sciences Corp.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.68x
Restart Life Sciences Corp.'s market cap is 0.68 times its annual revenue
1742.66x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $7.76K | $11.47K | -$25.23 Million | 0.68x | N/A |
Competitor Companies of NMLSD by Market Capitalization
Companies near Restart Life Sciences Corp. in the global market cap rankings as of March 18, 2026.
Key companies related to Restart Life Sciences Corp. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #158 globally with a market cap of $118.01 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.58 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #158 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $118.01 Billion | $466.10 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.58 Billion | $756.91 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Restart Life Sciences Corp. Historical Marketcap From 2020 to 2025
Between 2020 and today, Restart Life Sciences Corp.'s market cap moved from $7.76K to $ 503.79, with a yearly change of -46.24%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $503.79 | +109.20% |
| 2024 | $240.82 | -59.85% |
| 2023 | $599.75 | -81.43% |
| 2022 | $3.23K | +64.32% |
| 2021 | $1.97K | -74.67% |
| 2020 | $7.76K | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Restart Life Sciences Corp. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $503.79 USD |
| MoneyControl | $503.79 USD |
| MarketWatch | $503.79 USD |
| marketcap.company | $503.79 USD |
| Reuters | $503.79 USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.